IRIS
LUGARESI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.619
EU - Europa 10.614
AS - Asia 8.646
SA - Sud America 1.254
Continente sconosciuto - Info sul continente non disponibili 267
AF - Africa 139
OC - Oceania 13
Totale 34.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.346
SG - Singapore 3.296
IT - Italia 2.784
CN - Cina 2.477
UA - Ucraina 1.581
IE - Irlanda 1.346
TR - Turchia 1.094
GB - Regno Unito 1.088
BR - Brasile 999
RU - Federazione Russa 965
VN - Vietnam 820
FR - Francia 758
SE - Svezia 743
DE - Germania 593
FI - Finlandia 364
IN - India 281
CA - Canada 143
HK - Hong Kong 114
BD - Bangladesh 111
NL - Olanda 111
AR - Argentina 93
JP - Giappone 68
ZA - Sudafrica 59
PL - Polonia 58
KR - Corea 56
MX - Messico 56
ES - Italia 51
IQ - Iraq 48
EC - Ecuador 44
ID - Indonesia 40
IR - Iran 39
AT - Austria 31
CZ - Repubblica Ceca 27
CO - Colombia 26
CL - Cile 25
IL - Israele 24
BE - Belgio 22
EU - Europa 21
PY - Paraguay 21
JM - Giamaica 20
PK - Pakistan 20
MA - Marocco 19
SA - Arabia Saudita 18
VE - Venezuela 18
CR - Costa Rica 16
LT - Lituania 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
MY - Malesia 15
UY - Uruguay 14
AU - Australia 13
CH - Svizzera 13
KE - Kenya 13
NP - Nepal 13
TN - Tunisia 12
EG - Egitto 11
GR - Grecia 11
PH - Filippine 11
JO - Giordania 10
RS - Serbia 10
DK - Danimarca 8
PE - Perù 8
AZ - Azerbaigian 7
ET - Etiopia 7
HN - Honduras 7
KZ - Kazakistan 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
DO - Repubblica Dominicana 5
HR - Croazia 5
MK - Macedonia 5
RO - Romania 5
AM - Armenia 4
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
LB - Libano 4
NI - Nicaragua 4
BB - Barbados 3
BN - Brunei Darussalam 3
GE - Georgia 3
OM - Oman 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
CG - Congo 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
LU - Lussemburgo 2
LV - Lettonia 2
MM - Myanmar 2
MZ - Mozambico 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
Totale 34.278
Salva come PNG Salva come JPEG
Città #
Singapore 2.357
Jacksonville 1.785
Chandler 1.482
San Jose 1.409
Dublin 1.333
Southend 794
Council Bluffs 772
Dallas 710
Ashburn 677
Princeton 616
Izmir 599
Beijing 534
Nanjing 462
Wilmington 351
Ho Chi Minh City 311
Cambridge 302
Santa Clara 272
Los Angeles 270
The Dalles 215
Tongling 205
Altamura 199
Nanchang 181
New York 178
Hanoi 168
Dearborn 157
Buffalo 155
Ann Arbor 150
Rome 148
Milan 143
Moscow 131
Woodbridge 131
Hong Kong 106
Boardman 96
Shenyang 93
São Paulo 93
Jiaxing 88
Hebei 81
Munich 81
Chieti 75
Kunming 74
Houston 73
Tianjin 70
Redondo Beach 65
Norwalk 64
Columbus 63
Hefei 60
Bologna 48
Brooklyn 48
Naples 48
Grevenbroich 46
Seoul 46
Hangzhou 45
Tokyo 45
Montreal 43
Warsaw 43
Changsha 42
Florence 41
Phoenix 40
San Mateo 39
Torino 39
Washington 39
Helsinki 37
London 37
Orem 36
Toronto 36
Chicago 34
Da Nang 34
Haiphong 34
Johannesburg 34
Bari 33
Dong Ket 33
Turin 33
Frankfurt am Main 32
Atlanta 31
Stockholm 31
Leawood 30
Ardabil 29
Nuremberg 29
Rio de Janeiro 29
Denver 28
Turku 28
San Francisco 27
Boston 26
Genoa 26
Orange 26
Poplar 26
Augusta 25
Chennai 24
Jinan 24
Pisa 23
Seattle 23
Verona 23
Mexico City 22
Biên Hòa 21
Lanzhou 21
Brasília 20
Brno 20
Changchun 20
Belo Horizonte 19
Catania 19
Totale 20.114
Salva come PNG Salva come JPEG
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.825
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 487
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 238
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 225
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 222
Un caso di mieloneuropatia da HTLV- I in Italia 220
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 216
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 183
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 176
Cleavage of cystatin C is not associated with multiple sclerosis 171
IL 13 in multiple sclerosis 170
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 169
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 167
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 166
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 165
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 163
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 163
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 161
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 155
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 154
F response in vascular and degenerative upper motor neuron lesions 154
Increasing age at disability milestones among MS patients in the MSBase Registry 154
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 153
"Minimal" chronic inflammatory demyelinating polyneuropathy 152
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 151
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 148
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 148
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 148
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 147
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 145
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 145
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 143
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 142
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 142
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 141
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 140
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 140
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 140
Effect of TNF intraneural injection into the rat sciatic nerve 139
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 139
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 139
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 138
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 138
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 138
Chronic inflammatory demyelinating polyneuropathy in diabetes 137
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 137
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 135
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 135
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 134
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 134
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 134
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 134
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 133
Transdermal scopolamine cycloplegia in juvenile diabetes 132
Effect of rhTNF-alpha injection into rat sciatic nerve 132
Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy 131
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 131
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 131
Neurite ottica retrobulbare: studio biometrico del nervo ottico 130
Autoimmunity and interferon beta1B 130
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 130
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 129
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 129
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 128
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 128
Neurite ottica: relazione tra perimetria, PEV e RMN 127
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 127
Caratteristiche elettrofisiologiche della polineuropatia acuta assonale motoria associata ad elevato titolo di anticorpi anti-GD1a 126
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 126
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 126
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 126
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 125
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 125
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 125
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 125
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 125
Demyelinating motor Guillain-Barré syndrome following Rubella 125
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 124
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 124
JCV-Ab serostatus in MS patients treated with Natalizumab 124
76.Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy. 123
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of an italian cohort of 462 cases 123
Effects of IL10 on recombinant interferon-beta1b stimulated suppressor cell function in MS and controls subjects 122
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 122
Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. 122
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 121
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 121
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 121
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 121
Interferone beta: effetti collaterali 121
Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? 121
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 121
Effect of rhTNF-a injection into rat sciatic nerve 120
May electrophysiology differentiate chronic inflammatory demyelinating polyneuropathy (CIDP) and polineuropathy with anti- SGPG antibodies? 120
A prospective observational study to evaluate the safety and efficacy of serum-free subcutaneous Interferon-Beta 1A in patients with multiple sclerosis in the daily clinical setting, with a focus on injection-site reactions: preliminary results from sale. 120
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention. 120
rlFN-beta-1B stimulated suppressor cell function in multiple sclerosis: effects of anti-IL-10 monoclonal antibody 119
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 119
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 119
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 118
Totale 16.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.166 0 0 19 193 62 35 42 99 94 27 198 397
2022/20234.212 376 504 192 499 416 851 290 302 488 55 129 110
2023/20241.870 152 105 109 52 84 545 465 75 24 43 37 179
2024/20254.692 342 773 737 77 87 141 117 261 396 243 572 946
2025/202610.315 819 423 1.353 1.475 821 571 1.440 634 1.102 834 657 186
2026/2027880 219 554 107 0 0 0 0 0 0 0 0 0
Totale 34.552